Oncologists Accepting First Health in Boston, MA
327 verified oncologists in Boston, Massachusetts accept First Health. Profiles cover focus areas including Genitourinary Oncology, Medical Oncology, and Head & Neck Oncology. Common hospital affiliations include Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Newton-wellesley Hospital.
Ursula Matulonis, MD
Professor of Medicine, Harvard Medical School; Chief and Director, Division of Gynecologic Oncology, Dana-Farber Cancer Institute
Oncology
Robert Haddad, MD
Chief, Division of Head and Neck Oncology; McGraw Chair in Head and Neck Oncology; Professor of Medicine, Harvard Medical School
Oncology
Patrick Ott, MD
Professor of Medicine, Harvard Medical School; Clinical Director, Melanoma Disease Center; Director, Clinical Sciences, Center for Immuno-Oncology; Senior Physician
Oncology
Kenneth Anderson, MD
Kraft Family Professor of Medicine, Harvard Medical School; Director, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute
Oncology
Mary-Ellen Taplin, MD
Professor of Medicine, Harvard Medical School; Institute Physician and Director of Clinical Research, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Oncology
Muneeb Ahmed, M.D.
Miriam H. Stoneman Professor of Radiology, Harvard Medical School; Chief, Division of Vascular and Interventional Radiology, Beth Israel Deaconess Medical Center; Chair of the Imaging Department, Dana-Farber Cancer Institute
Oncology
Vincent Ho, MD
Professor of Medicine, Harvard Medical School; Director of Clinical Operations, Stem Cell Transplantation, Dana-Farber Cancer Institute
Oncology
Susana Campos, MD MPH
Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School
Oncology
Suzanne George, MD
Chief, Division of Sarcoma; Clinical Research Director, Sarcoma Center; Associate Professor of Medicine, Harvard Medical School
Oncology
Himisha Beltran, MD
Associate Professor of Medicine, Lank Center for Genitourinary Oncology and Division of Molecular and Cellular Oncology; Director of Translational Research, Medical Oncology
Oncology
Joseph Antin, MD
Chairman of the Steering Committee of the BMT Clinical Trial Network.; Chief, Stem Cell Transplantation, Emeritus
Oncology
Jennifer Chan, MD
Associate Professor of Medicine, Harvard Medical School; Clinical Director, Gastrointestinal Cancer Center; Director, Program in Carcinoid and Neuroendocrine Tumors, Dana-Farber Cancer Institute
Oncology
Robert Soiffer, MD
Chief of the Division of Hematologic Malignancies; Codirector of the Adult Stem Cell Transplantation Program; Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology, Harvard Medical School
Oncology
Harold Burstein, MD PHD
Director of Academic Partnerships; Director of Breast Cancer Education
Oncology
Liangge Hsu, MD
Assistant Professor of Radiology
Oncology
Stuart Schnitt, M.D.
Chief of Oncologic Pathology at the Dana-Farber Cancer Institute, Professor of Pathology at Harvard Medical School, and is an internationally recognized ex; Chief of Oncologic Pathology
Oncology
Howard Kaufman, M.D.
Professor, Surgery
Oncology
Erica Mayer, MD MPH
Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School; Director, Breast Cancer Clinical Research, Dana-Farber Breast Oncology Program
Oncology
Andrea Ng, MD
Director, Lymphoma/Hematologic Radiation Oncology
Oncology
Jennifer Ligibel, MD
Professor at Harvard Medical School and a Senior Physician in the Breast Oncology Center at the Dana-Farber Cancer Institute. Dr. Ligibel’s research focuses on; Director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living and has built a comprehensive clinical Healthy Living Program for patient
Oncology